WeVote
Log In

Bill

Bill

S 771

Increases the number of properties eligible for the coastal market assistance program

2025 Regular Session Introduced by Shelley Mayer

Eliminates preauthorization for initial inpatient detox and stabilization up to 14 days across state employee plans, MassHealth, and commercial plans to speed access.

SUBSTITUTED BY A425
0
WeVote Research Nonpartisan
Bill Summary · S 771

Summary — S.771 (2025): An Act relative to dual diagnosis treatment coverage

Note: the supplied bill metadata contained inconsistent items (an unrelated title and mixed sponsor lists). This summary is based on the bill text for Senate Bill No. 771 (filed Jan 15, 2025, presented by Senator John F. Keenan), titled in the text “An Act relative to dual diagnosis treatment coverage.” The bill was later substituted by House bill A425.

Purpose and intent

To expand and clarify insurance coverage for inpatient substance use disorder treatment and related post‑detoxification services, remove initial preauthorization barriers to timely care, and standardize definitions and procedures across state employee plans, Medicaid-contracted plans, and commercial carriers.

Key provisions

  • Amends multiple Massachusetts General Laws statutes (chapter 32A, section 17N; chapter 118E, section 10H; chapter 175, section 47GG) to harmonize definitions and coverage requirements.
  • Establishes/clarifies definitions:
    • “Acute treatment services”: 24‑hour medically supervised addiction treatment in a medically managed or medically monitored inpatient facility (DPH‑defined) including evaluation, withdrawal management, biopsychosocial assessment, counseling, psychoeducation and discharge planning.
    • “Clinical stabilization services”: 24‑hour clinically managed post‑detoxification treatment (usually following acute care) including intensive education, relapse prevention, family outreach and aftercare planning.
    • “Co‑occurring treatment services”: inpatient medically monitored detoxification provided in an inpatient psychiatric facility or psychiatric unit within a general hospital (licensed by Dept. of Mental Health).
  • Coverage and preauthorization rules:
    • Group Insurance Commission (state employees/retirees) must cover medically necessary acute treatment, clinical stabilization and co‑occurring services for up to 14 days without requiring preauthorization. GIC also must cover substance use disorder evaluations (per G.L. c.111, §51½) without preauthorization.
    • The Division of Medical Assistance and its contracted health insurers/plans/behavioral health administrators (MassHealth) must cover medically necessary acute treatment without preauthorization; clinical stabilization and co‑occurring services must be covered up to 14 days without preauthorization. MassHealth plans must also cover required substance use disorder evaluations without preauthorization.
    • Commercial carriers (chapter 175) are amended similarly (consistent coverage and preauthorization removal for initial care).
  • Notification and utilization review:
    • The treating facility must notify the insurer/carrier of admission and the initial treatment plan within 48 hours.
    • Insurers may initiate utilization review beginning on day 7 of the stay.
  • Medical necessity:
    • Medical necessity is to be determined by the treating clinician in consultation with the patient and documented in the patient’s medical record.

Who is affected

  • State employees and retirees insured through the Group Insurance Commission.
  • MassHealth beneficiaries and individuals covered by Medicaid managed care or primary care clinician plans and their contracted administrators.
  • Commercially insured individuals under plans governed by chapter 175.
  • Inpatient addiction treatment facilities, inpatient psychiatric units, hospitals, behavioral health management firms, third‑party administrators and insurers — operational procedures will change to accommodate notification and utilization review timing.
  • Clinicians and patients, who gain more authority for initial medical‑necessity determinations and reduced preauthorization delays.

Potential impact

  • Improves timely access to inpatient detox and early stabilization by eliminating immediate preauthorization requirements and guaranteeing at least up to 14 days of coverage without prior authorization.
  • May increase short‑term utilization and insurer payments for inpatient detox/stabilization services; insurers retain review rights beginning day 7 to manage length-of-stay appropriateness.
  • Standardizes expectations across state, Medicaid, and commercial plans, potentially simplifying admission procedures for facilities and clinicians.

Procedural status (as provided)

  • Introduced in Senate (1/15/2025). Referred to committee; recorded as substituted by A425. Various scheduling and committee actions appear in the record; House concurrence and other entries in the metadata are inconsistent with the bill text and should be verified against official legislative records for current status.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.